What is the recommended treatment and follow-up for neurosyphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Neurosyphilis: Treatment and Follow-Up

Primary Treatment Recommendation

Treat neurosyphilis with intravenous aqueous crystalline penicillin G 18-24 million units per day (administered as 3-4 million units IV every 4 hours or continuous infusion) for 10-14 days. 1

This is the gold standard recommended by CDC guidelines and remains the definitive treatment for all forms of neurosyphilis, including ocular and otic manifestations. 1


Treatment Regimens

First-Line Therapy

  • IV aqueous crystalline penicillin G: 18-24 million units daily, given as 3-4 million units IV every 4 hours OR continuous infusion for 10-14 days 1

Alternative Regimen (if compliance assured)

  • Procaine penicillin: 2.4 million units IM once daily PLUS
  • Probenecid: 500 mg orally four times daily for 10-14 days 1
  • Critical caveat: Do NOT use probenecid in patients with sulfa allergies, as cross-reactivity is likely 1

Supplemental Therapy Consideration

  • After completing the 10-14 day neurosyphilis regimen, consider adding benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks to provide comparable total duration to late-latent syphilis treatment 1
  • This supplementation is optional but recommended by some specialists since neurosyphilis regimens are shorter than late-latent syphilis protocols 1

Penicillin Allergy Management

For penicillin-allergic patients, desensitization followed by penicillin therapy is the preferred approach. 1

Alternative for True Penicillin Allergy

  • Ceftriaxone 2 g daily (IM or IV) for 10-14 days 1, 2
  • Important limitation: Cross-reactivity between ceftriaxone and penicillin exists 1
  • Recent meta-analysis (2024) showed ceftriaxone appears similar in efficacy to penicillin for neurosyphilis treatment, including in people living with HIV 2
  • If concern exists about ceftriaxone safety, perform penicillin skin testing (if available) to confirm allergy, then proceed with desensitization in consultation with a specialist 1

Follow-Up Protocol

CSF Monitoring (if initial pleocytosis present)

  • Repeat CSF examination every 6 months until cell count normalizes 1
  • CSF leukocyte count is the most sensitive measure of treatment effectiveness 1
  • CSF-VDRL and protein respond more slowly than cell counts; persistent abnormalities in these parameters are less concerning 1

Retreatment Criteria

  • If CSF cell count has not decreased after 6 months 1
  • If CSF cell count or protein is not normal after 2 years 1

Serum Serologic Monitoring

  • Monitor nontreponemal titers during 12-24 months post-treatment 1
  • In immunocompetent and virologically suppressed HIV-infected persons, normalization of serum RPR predicts CSF normalization 1
  • This finding suggests that follow-up CSF examinations may be reconsidered in patients whose symptoms and nontreponemal titers improve appropriately 1

Special Populations

HIV-Infected Patients

  • Use the same IV penicillin regimen as for HIV-negative patients 1
  • HIV-infected patients may have poorer CSF and serologic responses to therapy 1
  • For HIV-infected patients with neurosyphilis, repeat CSF examination at 3 and 6 months after completion of therapy, then every 6 months until CSF white blood cell count is normal and CSF-VDRL is nonreactive 1
  • All patients with syphilis should be tested for HIV 1

Ocular Syphilis

  • Treat as neurosyphilis with IV penicillin regimen regardless of CSF findings 1
  • Manage in collaboration with an ophthalmologist 1
  • Perform CSF examination on all patients with syphilitic eye disease (uveitis, neuroretinitis, optic neuritis) 1
  • Prevalence of CSF abnormalities in ocular syphilis ranges from 10-60% 1
  • Worse visual outcomes correlate with longer symptom duration before treatment and lower baseline visual acuity 1

Otic Syphilis

  • Many specialists recommend treating auditory disease as neurosyphilis regardless of CSF results 1
  • Systemic steroids are frequently used as adjunctive therapy but have not been proven beneficial 1

Common Pitfalls and Caveats

Diagnostic Considerations

  • CSF laboratory abnormalities are common in early syphilis even without clinical neurological findings; this does NOT warrant deviation from standard early syphilis treatment 1
  • Perform CSF examination only when clinical evidence of neurologic involvement exists: cognitive dysfunction, motor/sensory deficits, ophthalmic/auditory symptoms, cranial nerve palsies, or meningitis signs 1

Treatment Duration

  • The 10-14 day neurosyphilis regimen is shorter than the late-latent syphilis regimen, which is why supplemental benzathine penicillin is often considered 1

Serofast State

  • 15-20% of patients remain "serofast" with persistently low nontreponemal titers (usually <1:8) after successful treatment 1
  • This likely does NOT represent treatment failure 1
  • Reinfection should be diagnosed based on at least a fourfold increase in titer above the serofast baseline 1

Pregnancy

  • Pregnant patients allergic to penicillin should be desensitized and treated with penicillin 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.